Please provide your email address to receive an email when new articles are posted on . The trial will include a headband device and neurobiomarker platform to conduct EEG and sleep analyses in those ...
NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (DRUG), a biotechnology company focused on developing novel therapies for neurological and ...
Examination of EEG in healthy subjects administered single doses of BHV-7000 confirmed central nervous system (CNS) activity consistent with effects observed with other antiseizure medications. EEG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback